Regulus Therap (RGLS) Reports Q3 Loss of $15.98

November 19, 2012 4:20 PM

Regulus Therap (

NASDAQ: RGLS) reported Q3 EPS of ($15.98), versus ($11.68) reported last year. Revenue for the quarter came in at $2.8 million, versus $3.81 million reported last year.

For earnings history and earnings-related data on Regulus Therap (RGLS) click here.